SIGA Technologies Inc (SIGA) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.000x

Based on the latest financial reports, SIGA Technologies Inc (SIGA) has a cash flow conversion efficiency ratio of 0.000x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.66 Million) by net assets ($151.62 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SIGA equity to assets ratio to measure how much of total assets are equity-financed.

SIGA Technologies Inc - Cash Flow Conversion Efficiency Trend (1996–2025)

This chart illustrates how SIGA Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SIGA cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

SIGA Technologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SIGA Technologies Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Beetaloo Energy Australia Limited
AU:BTL
-0.055x
Medallion Metals Ltd
AU:MM8
-0.155x
Integrated Wind Solutions AS
OL:IWS
0.055x
Anhui Hyea Aromas Co Ltd
SHE:300886
-0.011x
ESAF Small Finance Bank
NSE:ESAFSFB
-0.810x
Dk Tech Co.Ltd
KQ:290550
0.079x
Shanghai Jin Jiang International Hotels Development Co Ltd B
SHG:900934
0.084x
Shanghai Xintonglian Packaging Co Ltd
SHG:603022
0.007x

Annual Cash Flow Conversion Efficiency for SIGA Technologies Inc (1996–2025)

The table below shows the annual cash flow conversion efficiency of SIGA Technologies Inc from 1996 to 2025. For the full company profile with market capitalisation and key ratios, see SIGA market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $198.82 Million $43.47 Million 0.219x -3.23%
2024-12-31 $215.80 Million $48.76 Million 0.226x -53.08%
2023-12-31 $196.86 Million $94.80 Million 0.482x +96.92%
2022-12-31 $170.16 Million $41.61 Million 0.245x +270.84%
2021-12-31 $174.31 Million $11.49 Million 0.066x -88.03%
2020-12-31 $129.79 Million $71.52 Million 0.551x +395.98%
2019-12-31 $97.78 Million $-18.20 Million -0.186x -127.82%
2018-12-31 $102.91 Million $68.87 Million 0.669x +2550.63%
2017-12-31 $-323.14 Million $-8.16 Million 0.025x -93.72%
2016-12-31 $-287.42 Million $-115.59 Million 0.402x +1129.66%
2015-12-31 $-284.43 Million $11.11 Million -0.039x +32.08%
2014-12-31 $-246.50 Million $14.18 Million -0.058x -101.67%
2013-12-31 $16.98 Million $58.44 Million 3.442x +592.75%
2012-12-31 $28.95 Million $-20.22 Million -0.699x -213.88%
2011-12-31 $41.69 Million $25.57 Million 0.613x +168.40%
2010-12-31 $12.07 Million $-10.83 Million -0.897x -11.06%
2009-12-31 $10.49 Million $-8.47 Million -0.808x +82.56%
2008-12-31 $1.55 Million $-7.20 Million -4.630x -344.34%
2007-12-31 $5.23 Million $-5.45 Million -1.042x -70.97%
2006-12-31 $7.28 Million $-4.44 Million -0.609x -41.42%
2005-12-31 $3.23 Million $-1.39 Million -0.431x +59.82%
2004-12-31 $4.56 Million $-4.89 Million -1.073x -11.66%
2003-12-31 $5.55 Million $-5.33 Million -0.961x +21.18%
2002-12-31 $2.17 Million $-2.65 Million -1.219x -46.58%
2001-12-31 $3.54 Million $-2.94 Million -0.831x +80.48%
2000-12-31 $924.74K $-3.94 Million -4.259x -202.25%
1999-12-31 $2.20 Million $-3.10 Million -1.409x -67.89%
1998-12-31 $5.60 Million $-4.70 Million -0.839x -456.03%
1997-12-31 $10.60 Million $-1.60 Million -0.151x +97.12%
1996-12-31 $400.00K $-2.10 Million -5.250x --

About SIGA Technologies Inc

NASDAQ:SIGA USA Drug Manufacturers - Specialty & Generic
Market Cap
$234.54 Million
Market Cap Rank
#15861 Global
#3730 in USA
Share Price
$3.27
Change (1 day)
+0.62%
52-Week Range
$3.10 - $9.48
All Time High
$22.50
About

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.